-
Bull, Housser & Tupper LLP
-
Business In Vancouver
-
Aurinia Pharmaceuticals
-
Aurora Biomed Inc.
-
A
-
BioTalent Canada
-
B
-
Nucleo Life Sciences
-
C
-
D
-
E
-
AbbVie Corporation
-
F
-
G
-
H
-
I
-
J
-
B.C. Technology Industry Association
-
ACCT Canada
-
K
-
BC Cancer Agency
-
L
-
BC Preclinical Research Consortium
-
M
-
Innovate BC
-
N
-
Biocan Diagnostics Inc.
-
O
-
P
-
Biolux Research Ltd.
-
Q
-
ACETECH
-
R
-
S
-
T
-
AdvantageBC
-
U
-
Biopep Solutions Inc.
-
BioPharma Solutions
-
Aequus Pharmaceuticals Inc
-
V
-
W
-
X
-
BIOTECanada
-
Ag-West Bio Inc.
-
Z
-
Blake, Cassels & Graydon LLP
-
Blender Media
-
Alectos Therapeutics Inc.
-
Boehringer Ingelheim (Canada) Ltd.
-
Amgen British Columbia Inc.
-
AON
-
Aquila Veterinary Diagnostics Ltd.
-
Aquinox Pharmaceuticals Inc.
-
Molecular You
-
Boreal Genomics
-
ARC Medical Devices Inc.
-
Aspect Biosystems Ltd.
-
Aspera, an IBM company
-
Bovicor Pharmatech Inc.
-
AstraZeneca Canada Inc.
-
Augurex Life Sciences Corp.
-
British Columbia Centre for Excellence in HIV/AIDS
-
British Columbia Clinical Research Infrastructure Network
Aurinia Pharmaceuticals
Address:
#1203 – 4464 Markham Street
Victoria BC
V8Z 7X8
Canada
Member Sector: Biopharmaceuticals
Aurinia is a late stage biopharmaceutical company focused on the development of its novel therapeutic immunomodulating drug candidate, voclosporin, for the treatment of lupus nephritis. Our strategy is to leverage our team’s past clinical experience in lupus and the Aspreva Lupus Management Study (ALMS) database in order to inform and guide our clinical development plans within this therapeutic area.